Key Insights

Highlights

Treatment Research

2 treatments under study, led by Liver Biopsy

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Withdrawn1
Enrolling By Invitation1

Clinical Trials (2)

Showing 2 of 2 trials
NCT07216508Enrolling By Invitation

Liver Transplant CGM

NCT00834496Withdrawn

Switching From One Type of Anti-rejection Drug (Tacrolimus or Cyclosporine) to Another (Sirolimus) Approximately 90-180 Days After Liver Transplantation

Showing all 2 trials

Research Network

Common Treatments

  • Liver Biopsy1
  • Libre 31

Active Sponsors

  • Thomas Jefferson University1
  • Wyeth is now a wholly owned subsidiary of Pfizer1
  • Icahn School of Medicine at Mount Sinai1

Top Investigators

Related Conditions

  • Side Effects Of Calcineurin Inhibitors1
  • Hepatic Fibrosis On Biopsy1
  • Type 2 Diabetes1
  • Neurotoxicity1
  • Liver Transplant1

Activity Timeline